Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura

Annals of Hematology

Volumn 87, Issue 12, 2008, Pages 975-983

  Houwerzijl, Ewout J ^a   Louwes, Henk ^b   Sluiter, Wim J ^a   Smit, Jan W ^b   Vellenga, Edo ^a   Wolf, Joost Th M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

ITP; Megakaryocytes; Platelet kinetic studies; Platelet production; Platelets; Thrombokinetics

Indexed keywords

CYCLOSPORIN; DANAZOL; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE KINETICS; THROMBOCYTOPOIESIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PREDNISONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; SPLENECTOMY; THROMBOPOIESIS;

EID: 55649102303     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0537-1     Document Type: Article

References (46)

1. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J (2004) Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103:1364-1369 doi: 10.1182/ blood-2003-08-2672
2. Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS et al (2003) Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 102:887-895 doi: 10.1182/blood-2002-05-1475
3. Houwerzijl EJ, Blom NR, van der Want JJ, Esselink MT, Koornstra JJ, Smit JW et al (2004) Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood 103:500-506 doi: 10.1182/ blood-2003-01-0275
4. Emmons RV, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE et al (1996) Human thrombopoietin (TPO) levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068-4071
5. Steinberg MH, Kelton JG, Coller BS (1987) Plasma glycocalicin. An aid in the classification of thrombocytopenic disorders. N Engl J Med 317:1037-1042
6. Hersh J (2000) Mathematical analysis of the relative contributions of decreased production and increased peripheral destruction in idiopathic thrombocytopenic purpura and implications in splenectomy. J Theor Biol 203:153-162 doi: 10.1006/jtbi.2000.1072
7. Kojouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 104:2623-2634 doi: 10.1182/ blood-2004-03-1168
8. Siegel RS, Rae JL, Barth S, Coleman RE, Reba RC, Kurlander R et al (1989) Platelet survival and turnover: Important factors in predicting response to splenectomy in immune thrombocytopenic purpura. Am J Hematol 30:206-212 doi: 10.1002/ajh.2830300404
9. Gernsheimer T, Stratton J, Ballem PJ, Slichter SJ (1989) Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med 320:974-980
10. Louwes H, Vellenga E, Houwerzijl EJ, de Wolf JT (2001) Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: Only splenectomy induces a complete remission. Ann Hematol 80:728-732 doi: 10.1007/s002770100375
11. Branehög I, Weinfeld A (1974) Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP) before and during treatment with corticosteroids. Scand J Haematol 12:69-79
12. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al (1996) Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3-40
13. ICSH Panel on Diagnostic Application of Radionuclides (1988) Recommended method for Indium-111 platelet survival studies. J Nucl Med 29:564-566
14. Bowring CS (1981) Radionuclide tracer techniques in haematology. Butterworths, London, pp 40-41
15. Harker LA, Finch CA (1969) Thrombokinetics in man. J Clin Invest 48:963-974 doi: 10.1172/JCI106077
16. Louwes H, van Schuur JJ (1990) Platelet labelling with 111 In-tropolonate. In: Kessler CH, Hardeman MR, Henningsen H, Petrovici JN (eds) Clinical application of radiolabelled platelets. Kluwer Academic, Dordrecht, pp 45-60
17. Fleming JS (1979) A technique for the measurement of activity using a gamma camera and computer. Phys Med Biol 24:176-180 doi: 10.1088/ 0031-9155/24/1/017
18. Cines DB, McMillan R (2005) Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 56:425-442 doi: 10.1146/ annurev.med.56.082103.104644
19. Thompson RL, Moore RA, Hess CE, Wheby MS, Leavell BS (1972) Idiopathic thrombocytopenic purpura. Long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Intern Med 130:730-734 doi: 10.1001/archinte.130.5.730
20. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T (1991) High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 77:31-33
21. Pizzuto J, Ambriz R (1984) Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric trial of the Cooperative Latin American Group on Hemostasis and Thrombosis. Blood 64:1179-1183
22. Ikkala E, Kivilaakso E, Kotilainen M, Hastbacka J (1978) Treatment of idiopathic thrombocytopenic purpura in adults. Long-term results in a series of 41 patients. Ann Clin Res 10:83-86
23. Meyers MC (1961) Results of treatment in 71 patients with idiopathic thrombocytopenic purpura. Am J Med Sci 242:295-302 doi: 10.1097/ 00000441-196109000-00004
24. DiFino SM, Lachant NA, Kirshner JJ, Gottlieb AJ (1980) Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 69:430-442 doi: 10.1016/0002-9343(80)90016-9
25. den Ottolander GJ, Gratama JW, de Koning J, Brand A (1984) Long-term follow-up study of 168 patients with immune thrombocytopenia. Implications for therapy. Scand J Haematol 32:101-110
26. Jacobs P, Wood L, Dent DM (1986) Results of treatment in immune thrombocytopenia. Q J Med 58:153-165
27. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F et al (1995) Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 98:436-442 doi: 10.1016/ S0002-9343(99)80342-8
28. Grossi A, Vannucchi AM, Casprini P, Guidi S, Rafanelli D, Pecchioli MG et al (1983) Different patterns of platelet turnover in chronic idiopathic thrombocytopenic purpura. Scand J Haematol 31:206-214
29. Stratton JR, Ballem PJ, Gernsheimer T, Cerqueira M, Slichter SJ (1989) Platelet destruction in autoimmune thrombocytopenic purpura: Kinetics and clearance of indium-111-labeled autologous platelets. J Nucl Med 30:629-637
30. Louwes H, Zeinali Lathori OA, Vellenga E, de Wolf JT (1999) Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura. Am J Med 106:430-434 doi" 10.1016/S0002-9343(99)00054-6
31. Van De Loosdrecht AA, Hendriks DW, Blom NR, Smit JW, De Wolf JT, Vellenga E (2000) Excessive apoptosis of bone marrow erythroblasts in a patient with autoimmune haemolytic anaemia with reticulocytopenia. Br J Haematol 108:313-315 doi: 10.1046/j.1365-2141.2000.01867.x
32. Heyns AP, Lotter MG, Badenhorst PN, de Kock F, Pieters H, Herbst C et al (1982) Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: A quantitative study. Am J Hematol 12:167-177 doi: 10.1002/ajh.2830120209
33. Stoll D, Cines DB, Aster RH, Murphy S (1985) Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood 65:584-588
34. Schmidt KG, Rasmussen JW (1985) Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura. Scand J Haematol 34:47-56
35. Heyns AP, Badenhorst PN, Lotter MG, Pieters H, Wessels P, Kotze HF (1986) Platelet turnover and kinetics in immune thrombocytopenic purpura: Results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood 67:86-92
36. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ (1987) Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 80:33-40 doi: 10.1172/ JCI113060
37. Rolovic Z, Baldini M, Dameshek W (1970) Megakaryocytopoiesis in experimentally induced immune thrombocytopenia. Blood 35:173-188
38. Dixon R, Rosse W, Ebbert L (1975) Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. N Engl J Med 292:230-236
39. Tate DY, Sorenson RL, Gerrard JM, White JG, Krivit W (1977) An immunoenzyme histochemical technique for the detection of platelet antibodies from the serum of patients with idiopathic (autoimmune) thrombocytopenic purpura (ITP). Br J Haematol 37:265-275 doi: 10.1111/ j.1365-2141.1977.tb06843.x
40. Shulman NR, Weinrach RS, Libre EP, Andrews HL (1965) The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am Physicians 78:374-390
41. Handin RI, Stossel TP (1978) Effect of corticosteroid therapy on the phagocytosis of antibody-coated platelets by human leukocytes. Blood 51:771-779
42. Fujisawa K, Tani P, Piro L, McMillan R (1993) The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood 81:2872-2877
43. Berchtold P, Wenger M (1993) Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: Their clinical significance and response to treatment. Blood 81:1246-1250
44. McMillan R, Longmire RL, Tavassoli M, Armstrong S, Yelenosky R (1974) In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura. N Engl J Med 290:249-251
45. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT et al (2006) AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 355:1672-1681 doi: 10.1056/NEJMoa054626
46. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM et al (2008) Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial. Lancet 371:395-403